Novel Diagnosis and Therapeutic of Uveal Melanoma: 2nd Edition

A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".

Deadline for manuscript submissions: closed (31 January 2024) | Viewed by 249

Special Issue Editors


E-Mail Website
Guest Editor
Department of Ophthalmology, Faculty of Medicine, Comenius University, 826 01 Bratislava, Slovakia
Interests: ophthalmology; melanoma; uveal melanoma
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Ophthalmology, Erasmus MC Rotterdam, 3000 CA Rotterdam, The Netherlands
Interests: uveal melanoma; microRNA; genetics; prognostication; ctDNA; CTC
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Health Science Center, University of Texas, Houston, TX, USA
Interests: retinoblastoma; uveal melanoma; intraocular and conjunctival malignancies

Special Issue Information

Dear Colleagues,

The first volume of the Special Issue “Novel Diagnosis and Therapeutic of Uveal Melanoma” (https://www.mdpi.com/journal/life/special_issues/VH45KYJ657)  was closed, and it is our pleasure to announce the second volume.

Intraocular uveal melanoma is the most prevalent intraocular tumor in adults, and liver is the most common site of its metastases. Different imaging techniques are utilized in diagnostics, i.e., fundus imaging (FI), ultrasonography (US), optical coherence tomography (OCT), single-photon emission computed tomography (SPECT), positron emission tomography/computed tomography (PET/CT), magnetic resonance imaging (MRI), fundus fluorescein angiography (FFA), indocyanine green angiography (ICGA), or fundus autofluorescence (FAF), but sometimes, the precision and quality of the obtained images are imperfect, raising diagnostic doubts and prompting the search for new ones. New experimental techniques that may be adapted to clinical practice in the future and also molecular and genetic techniques and perspective for personalized medicine in uveal melanoma treatment are the aims of this issue.

Dr. Alena Furdova
Dr. Emine Kilic
Dr. Dan S. Gombos
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • uveal melanoma
  • intraocular tumors
  • metastatic model of uveal melanoma
  • diagnostics of uveal melanoma
  • treatment options in uveal melanoma

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop